文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

免疫抑制与重症监护病房获得性多重耐药菌定植和感染的关系:一项前瞻性多中心队列研究

Relationship between immunosuppression and intensive care unit-acquired colonization and infection related to multidrug-resistant bacteria: a prospective multicenter cohort study.
PubMed 文献 · Intensive Care Med · 2023-01-02
一句话结论免疫抑制患者ICU获得性多重耐药菌定植和/或感染的复合结局发生率显著更低(调整发生率比0.68,95%CI 0.52-0.91)。

该研究在法国8个ICU开展前瞻性观察性队列研究,纳入750例ICU停留>48小时的患者,其中264例(35.2%)为免疫抑制患者。患者入院时及之后每周进行多重耐药菌定植系统筛查,随访28天。主要终点为ICU获得性多重耐药菌定植和/或感染的复合结局发生率。调整中心和预设基线混杂因素后,免疫抑制患者的复合结局发生率更低(调整发生率比0.68,95%CI 0.52-0.91);单独分析时,定植差异显著,感染差异不显著。作者认为这一发现提示接触隔离和隔离措施的作用,并可能对该人群的抗生素管理有重要启示。

要点

  • 在8个法国ICU的750例患者中,免疫抑制患者占35.2%(264例),其ICU获得性多重耐药菌定植和/或感染复合结局发生率更低(调整发生率比0.68,95%CI 0.52-0.91)。
  • 单独分析时,免疫抑制与ICU获得性多重耐药菌定植的差异显著,但与ICU获得性多重耐药菌感染的差异不显著。
  • 两组间多重耐药菌分布相当,以对第三代头孢菌素耐药的大肠埃希菌科细菌为主(约74%)。
  • 作者指出该发现提示接触隔离和隔离措施的作用,并可能对该人群的抗生素管理有重要启示。

适用人群与场景

  • 法国8个ICU(均为单间病房且组织特征相似)中所有连续入住ICU且停留>48小时的患者,无论免疫状态均纳入,随访28天。
  • 免疫抑制定义为活动性癌症或血液系统恶性肿瘤、中性粒细胞减少、实体器官移植、使用类固醇或免疫抑制药物、人类免疫缺陷病毒感染及遗传性因素。

诊断标准与关键阈值

  • 免疫抑制定义:活动性癌症或血液系统恶性肿瘤、中性粒细胞减少、实体器官移植、使用类固醇或免疫抑制药物、人类免疫缺陷病毒感染及遗传性因素。

研究设计与关键结果

  • 研究类型:前瞻性观察性队列研究,8个ICU,纳入750例患者(65.9%男性,中位年龄65岁),其中264例(35.2%)为免疫抑制患者。
  • 两组ICU入住原因、严重度评分及ICU期间有创设备和抗生素暴露相当。
  • 主要终点:调整中心和预设基线混杂因素后,免疫抑制患者ICU获得性多重耐药菌定植和/或感染的复合结局发生率更低(调整发生率比0.68,95%CI 0.52-0.91)。
  • 单独分析:ICU获得性多重耐药菌定植差异显著,但ICU获得性多重耐药菌感染差异不显著。
  • 两组多重耐药菌分布相当,以对第三代头孢菌素耐药的大肠埃希菌科细菌为主(约74%)。

证据类型、等级与局限

  • 证据类型:前瞻性观察性多中心队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,该发现提示接触隔离和隔离措施的作用,并可能对该人群的抗生素管理有重要启示。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: The impact of immunosuppression on intensive care unit (ICU)-acquired colonization and infection related to multidrug-resistant (MDR) bacteria (ICU-MDR-col and ICU-MDR-inf, respectively) is unknown.

METHODS: We carried out an observational prospective cohort study in 8 ICUs in France (all with single-bed rooms and similar organizational characteristics). All consecutive patients with an ICU stay > 48 h were included, regardless of immune status, and followed for 28 days. Patients underwent systematic screening for colonization with MDR bacteria upon admission and every week subsequently. Immunosuppression was defined as active cancer or hematologic malignancy, neutropenia, solid-organ transplant, use of steroids or immunosuppressive drugs, human immunodeficiency virus infection and genetic. The primary endpoint was the incidence rate of a composite outcome including ICU-MDR-col and/or ICU-MDR-inf.

RESULTS: 750 patients (65.9% males, median age 65 years) were included, among whom 264 (35.2%) were immunocompromised. Reasons for ICU admission, severity scores and exposure to invasive devices and antibiotics during ICU stay were comparable between groups. After adjustment for center and pre-specified baseline confounders, immunocompromised patients had a lower incidence rate of ICU-MDR-col and/or ICU-MDR-inf (adjusted incidence ratio 0.68, 95% CI 0.52-0.91). When considered separately, the difference was significant for ICU-MDR-col, but not for ICU-MDR-inf. The distribution of MDR bacteria was comparable between groups, with a majority of Enterobacteriacae resistant to third-generation cephalosporins (~ 74%).

CONCLUSION: Immunocompromised patients had a significantly lower incidence rate of a composite outcome including ICU-MDR-col and/or ICU-MDR-inf. This finding points to the role of contact precautions and isolation measures, and could have important implications on antibiotic stewardship in this population.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Kreitmann L, Vasseur M, Jermoumi S, et al. Relationship between immunosuppression and intensive care unit-acquired colonization and infection related to multidrug-resistant bacteria: a prospective multicenter cohort study. Intensive Care Med. 2023. PMID: 36592202. doi:10.1007/s00134-022-06954-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。